Ascentage Pharma Group International Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Jun 24 | Buy€70,046,821 | Takeda Pharmaceutical Company Limited | Company | 24,307,322 | €2.88 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 202,972 | 0.0657% |
Public Companies | 24,307,322 | 7.87% |
Institutions | 25,586,506 | 8.28% |
Private Companies | 64,282,957 | 20.8% |
General Public | 194,649,191 | 63% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
50,616,519 | €153.0m | 0% | no data | |||
24,307,322 | €73.5m | 0% | no data | |||
13,666,438 | €41.3m | 0% | no data | |||
6,410,800 | €19.4m | -1.08% | no data | |||
3,947,400 | €11.9m | 0.72% | no data | |||
3,718,600 | €11.2m | 0% | 0.06% | |||
2,990,110 | €9.0m | 0% | 0.01% | |||
2,569,400 | €7.8m | 0% | 0.02% | |||
2,162,000 | €6.5m | 0% | 0.02% | |||
629,169 | €1.9m | 0% | no data | |||
611,700 | €1.8m | 0% | 0.01% | |||
559,000 | €1.7m | 0% | 0.01% | |||
501,919 | €1.5m | -3.96% | no data | |||
459,689 | €1.4m | 0% | no data | |||
363,500 | €1.1m | 0% | 0.39% | |||
181,900 | €549.8k | 0% | no data | |||
126,000 | €380.9k | 0% | no data | |||
117,259 | €354.4k | 4.33% | no data | |||
112,500 | €340.0k | 0% | no data | |||
85,800 | €259.3k | 0% | 0.15% | |||
76,972 | €232.7k | 0% | no data | |||
48,811 | €147.5k | 0% | 0.02% | |||
42,100 | €127.2k | 0% | 0.01% | |||
31,008 | €93.7k | 0% | no data | |||
16,300 | €49.2k | -12.8% | no data |